FDA Speaks Loudly On Approved Claims Language In Post Foods Warning
This article was originally published in The Tan Sheet
Executive Summary
Similar claims likely are made for products marketed by others firms of various sizes, but a single warning letter to a manufacturer the size of Post Food speaks louder than similar letters to numerous smaller companies.
You may also be interested in...
ConAgra’s Petition For Whole Grain/Diabetes Claim Draws Opposition
Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.
FDA's Flurry Of Food Claim Warnings Sends Bold Enforcement Message
A spate of FDA warning letters detailing labeling violations and an open letter from Commissioner Margaret Hamburg largely quash any hopes the food industry might have had for regulatory latitude to make aggressive health claims
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.